Results 141 to 150 of about 6,757 (189)

Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial. [PDF]

Nat Cancer
Melero I, Reis B, Rusterholz C, Epp A, Kratochwil NA, Wu C, Hettich M, Kazantzidis G, Rieder N, Schwalie PC, Badillo S, Kumpesa N, Thommen A, Vugts DJ, Moreno V, Lostes Bardaji J, Alvarez EC, de Andrea CE, Spanggaard I, Lee DH, Spicer J, Thistlethwaite F, Oh DY, Hollebecque A, Cirovic O, Symeonides SN.   +25 more
europepmc   +1 more source

Dietary β-1,3/1,6-Glucan from Baker's Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial. [PDF]

Nutrients
Kanno T, Ishibashi KI, Kajiyama S, Ikawa T, Morita T, Murata K, Imai S, Nishioka M, Adachi Y.   +8 more
europepmc   +1 more source

Dendritic cells in the lung cavities of extensively drug-resistant tuberculosis patients exhibit altered frequency and phenotype. [PDF]

ERJ Open Res
Londt R, Semple L, Pooran A, Esmail A, Davids M, Dheda K, Tomasicchio M.   +6 more
europepmc   +1 more source

Lactococcus lactis-HSP65 requires TLR2 to induce tolerogenic dendritic cells and confer protection against type 1 diabetes in a murine model. [PDF]

Cell Mol Life Sci
Elias-Oliveira J, Rodrigues VF, Pereira ÍS, Barbosa SC, Pereira JA, Pacheco TCF, Machado MSG, Masson AP, Rios WM, Gardinassi LG, Miyoshi A, Azevedo V, Silva CL, Tostes RC, Carlos D.   +14 more
europepmc   +1 more source

Characterizing the myeloid and lymphoid immune response in a porcine model of pulmonary ischemia-reperfusion injury through flow cytometry. [PDF]

PLoS One
Duong A, Mariscal A, Caldarone L, Xu C, Huang L, Ramendra R, Keshavjee S, Liu M, Juvet S, Martinu T.   +9 more
europepmc   +1 more source

Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine. [PDF]

J Exp Med
Tam H, Shen H, Xu Y, An J, Cyster JG.
europepmc   +1 more source

Dendritic cells: the central partner for cancer immunity. [PDF]

Oncoimmunology
Laoubi L, Gobbini E, Duplouye P, Hubert M, Caux C, Bendriss-Vermare N, Valladeau-Guilemond J, Voissière A.   +7 more
europepmc   +1 more source

IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 Immunotherapy. [PDF]

Cancer Immunol Res
Avanessian SC, van den Bijgaart RJE, Chew NW, Supper VM, Tang TT, Zhang Y, Zhao YQ, Abe K, Gauthier J, Barry KC.   +9 more
europepmc   +1 more source

In Situ Engineering of Tumor Cells as Self-Sustaining cDC1 Programming Factories for Effective Cancer Immunotherapy. [PDF]

Adv Sci (Weinh)
Jin S, Wang X, Li B, Zhu X, Liu Z, Lu J, Wei Y, Wu Z, Li K, Zhang T, He Z, Zhu P, Qi Y, Liu B, Liu H, Wang Y, Chen Z.   +16 more
europepmc   +1 more source